Image

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases

Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases

Recruiting
18-99 years
All
Phase N/A

Powered by AI

Overview

The purpose of this multi-center, randomized, clinical study is to show that the treatment of degenerative lumbar spine with high- or mid-flex rods is not inferior to the treatment with low-flex rods in terms of clinical and safety-related results.

The primary aim is to compare the reduction in back pain after the treatment with highor mid-flex rods with that after treatment with low-flex rods. Secondary, the functionality after treatment with high- or mid-flex rods will be compared to that after treatment with low-flex rods.

Description

Dynamic stabilization systems for the lumbar spine are no novelty. The SpineShape System IV builds on the experience of previous systems and attempts to provide additional benefits primarily through three different and relatively elastic rod stiffnesses. 126 subjects with degenerative symptoms in 1 to 2 segments of the lumbar spine L1 to S1 will be recruited. The participants will be randomized in a 1:1:1 ratio to undergo implantation of either the elastic (experimental product group 1), medium (experimental product group 2) or stiff rod (comparison product group).

The aim of the study is to show that the treatment of degenerative lumbar spine with elastic or medium rod variants is not inferior to treatment with hard rods in terms of clinical and safety-related results. This is checked by completing a questionnaire before the surgical procedure and 3 months, 12 months, 24 months and 60 months after the surgical procedure.

Eligibility

Inclusion Criteria:

  • degenerative symptoms in 1 to 2 segments in the lumbar spine L1-S1
  • signed informed consent of participant
  • confirmation of the participant that the attendance of follow-up visits are intended
  • Body-Mass-Index < 32
  • Pedicle screw axis distance < 30mm
  • one or more of the following indications:
    • (dynamic) stenosis in the spinal canal
    • neuroforaminal stenosis
    • facet joint syndrome / spondylarthrosis
    • discopathy (recurrent disc hernia)
    • degenerative spondylolisthesis (Meyerding <1)
    • instability (hypermobility with antelishtesis, hypomobility with retrolisthesis if decompressed)

Exclusion Criteria:

  • missing bone structure, e.g. due to congenital anomalies or sever anatomical deformities that make anchoring of the implant impossible
  • damaged structural tissue, e.g. due to a bone fracture
  • application to the thoracic or cervical spine
  • pronounced idiopathic scoliosis
  • spondylolisthesis > Meyerding grad 1
  • isthmic spondolylysis
  • bone tumor
  • osteochondrosis modic type I, II or III
  • osteoporosis, which could impair screw anchoring
  • history with third party implants
  • patients with an active local or systemic infection
  • known allergy to titatnium alloys
  • skeleton in growth (epiphyseal joints not closed)
  • severe muscular neuronal or vascular disease
  • immunosuppresive therapy
  • long-term therapy with cortisone
  • heavy smokers (regular consumption of more than six cigarettes per day), drug addicts and alcoholics
  • chronic pain patients
  • incapable of judgment or emergency situation
  • implantation during pregnancy

Study details
    Degenerative Lumbar Spinal Stenosis
    Facet Joint Arthrosis
    Spondylarthritis
    Discopathy
    Degenerative Spondylolisthesis
    Instability Lumbar Spine

NCT06320899

SpineSave AG

6 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.